Kenneth J. Gorelick, Director at Neurotrope, Inc. (NTRP), bought 5,000 shares at $0.41 ($2K) on 2016-08-26, disclosed to the SEC on 2016-08-29.
Open-market purchase of $2k NTRP by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.